The Firm Makes use of Packaging for its Tauri-Gummies™ Product, that’s Each: Environmentally Pleasant and Baby Proof
NEW YORK, NY, Might 15, 2020 (GLOBE NEWSWIRE) — by way of NEWMEDIAWIRE — Tauriga Sciences, Inc. (OTCQB: TAUG) (“Tauriga” or the “Firm”), a income producing Firm that operates by means of the event, distribution, and licensing of proprietary merchandise in addition to the analysis of potential acquisition alternatives and fairness investments, as we speak introduced that it has commenced its 2nd manufacturing run of its plant primarily based Cannabidiol (“CBD”) infused Gum Drop product, branded as: Tauri-Gummies™. The preliminary manufacturing run was accomplished throughout January 2020, for a complete of 1,00zero Models (“Jar” or “Pack”). This 2nd manufacturing run, which is predicted to be accomplished throughout the subsequent 2-Three weeks, will yield a complete of two,200 Jars. Tauri-Gummies™ gross sales have been constantly robust on the Firm’s E-Commerce platform (www.taurigum.com). Every Jar of the Firm’s Tauri-Gummies™ product, has a longtime MSRP of $24.99.
The Firm’s Tauri-Gummies™ product is Gelatin-Free and consists of four distinct Gum Drop flavors – Format: 1950s nostalgic model. These flavors are: Cherry (crimson), Orange (orange), Lemon (yellow), and Lime (inexperienced).
ABOUT TAURIGA SCIENCES INC.
Tauriga Sciences, Inc. (TAUG) is a income producing, diversified life sciences firm, engaged in a number of main enterprise actions and initiatives. The corporate manufactures and distributes a number of proprietary retail merchandise and product traces, primarily centered on the Cannabidiol (“CBD”) and Cannabigerol (“CBG”) Edibles market phase. The primary product line, branded as Tauri-Gum™, consists of a proprietary complement chewing gum that’s each Kosher licensed and Vegan formulated (CBD Infused Tauri-Gum™ Flavors: Mint, Blood Orange, Pomegranate) & (CBG Infused Tauri-Gum™ Taste: Peach-Lemon). The Firm’s commercialization technique consists of a broad array of retail prospects, distributors, and a fast-growing E-Commerce enterprise phase (E-Commerce web site: www.taurigum.com). Please go to our company web site, for added data, in addition to inquiries, at www.tauriga.com.
Complementary to the Firm’s retail enterprise, are its two ongoing biotechnology initiatives. The primary one pertains to the event of a Pharmaceutical grade model of Tauri-Gum™, for nausea regulation (particularly designed to assist sufferers which might be subjected to ongoing chemotherapy therapy). On March 18, 2020, the Firm introduced that it filed a provisional U.S. patent utility overlaying its pharmaceutical grade model of Tauri-Gum™. The Patent, filed with the usP.T.O. is Titled “MEDICATED CBD COMPOSITIONS, METHODS OF MANUFACTURING, AND METHODS OF TREATMENT”. The second pertains to a collaboration settlement with Aegea Biotechnologies Inc. for the co-development of a speedy, multiplexed, Novel Coronavirus (COVID-19) take a look at with superior sensitivity and selectivity.
The Firm is headquartered in New York Metropolis and operates a regional workplace in Barcelona, Spain. As well as, the Firm operates a full time E-Commerce success heart situated in LaGrangeville, New York.
DISCLAIMER — Ahead-Trying Statements
This press launch incorporates sure “forward-looking statements” as outlined by the Personal Securities Litigation Reform Act of 1995 which characterize administration’s beliefs and assumptions regarding future occasions. These forward-looking statements are sometimes indicated by utilizing phrases resembling “could,” “will,” “expects,” “anticipates,” believes, “hopes,” “believes,” or plans, and will embrace statements relating to company aims in addition to the attainment of sure company objectives and milestones. Ahead-looking statements are primarily based on current circumstances and on administration’s current beliefs with respect to occasions that haven’t occurred, that won’t happen, or which will happen with totally different penalties or timing than these now assumed or anticipated. Precise outcomes could differ materially from these expressed in ahead trying statements as a consequence of recognized and unknown dangers and uncertainties, resembling usually are not ensures of common financial and enterprise situations, the flexibility to efficiently develop and market merchandise, shopper and enterprise consumption habits, the flexibility to consummate profitable acquisition and licensing transactions, fluctuations in change charges, and different components over which Tauriga has little or no management. Many of those dangers and uncertainties are mentioned in larger element within the “Threat Components” part of Tauriga’s Type 10-Okay and different filings made sometimes with the Securities and Change Fee. Such forward-looking statements are made solely as of the date of this launch, and Tauriga assumes no obligation to replace forward-looking statements to mirror subsequent occasions or circumstances. You shouldn’t place undue reliance on these forward-looking statements.
Tauriga Sciences, Inc.
555 Madison Avenue, fifth Ground
New York, NY 10022
Chief Government Officer
Mr. Seth M. Shaw
Electronic mail: email@example.com
cell # (917) 796 9926
Corp. Web site: www.tauriga.com
E-Commerce Web site: www.taurigum.com